HER2-positive breast cancer: the story goes on
Chamberlin, M.D.; Kaufman, P.A.
Oncology 28(4): 290; 292-293
2014
ISSN/ISBN: 0890-9091 PMID: 24839798 Document Number: 677325
Document emailed within 1 workday
Related Documents
Rudan, I.; Skorić, T.; Rudan, N. 1994: Breast cancer prognosis. II. Prognostic factors in patients with node-positive (N1-3) breast cancer Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 48(4-5): 165-170Henry, N.L.; Hayes, D.F.; Rae, J.M. 2009: CYP2D6 testing for breast cancer patients: is there more to the story? Oncology 23(14): 1236; 1243, 1249
Partridge, A.H.; Niman, S.M.; Ruggeri, M.; Peccatori, F.A.; Azim, H.A.; Colleoni, M.; Saura, C.; Shimizu, C.; Sætersdal, A.B.; Kroep, J.R.; Mailliez, A.; Warner, E.; Borges, V.F.; Amant, F.éd.ér.; Gombos, A.; Kataoka, A.; Rousset-Jablonski, C.; Borstnar, S.; Takei, J.; Lee, J.E.; Walshe, J.M.; Borrego, M.R.íz.; Moore, H.C.; Saunders, C.; Cardoso, F.; Susnjar, S.; Bjelic-Radisic, V.; Smith, K.L.; Piccart, M.; Korde, L.A.; Goldhirsch, A.; Gelber, R.D.; Pagani, O. 2021: Who are the women who enrolled in the POSITIVE trial: a global study to support young hormone receptor positive breast cancer survivors desiring pregnancy Breast 59: 327-338
Wiratkapun, C.; Bunyapaiboonsri, W.; Wibulpolprasert, B.; Lertsithichai, P. 2010: Biopsy rate and positive predictive value for breast cancer in BI-RADS category 4 breast lesions Journal of the Medical Association of Thailand 93(7): 830-837
Merritt, D.D.; Liles, B.Z. 1987: Story grammar ability in children with and without language disorder: story generation, story retelling, and story comprehension Journal of Speech and Hearing Research 30(4): 539-552
Merritt, D.D.; Liles, B.Z. 1987: Story grammar ability in children with and without language disorder: story generation, story retelling, and story comprehension Journal of Speech and Hearing Research 30(4): 539-552
Salvadori, B.; Celio, L.; Oriana, R.; Bajetta, E. 2000: Adjuvant oophorectomy versus CMF in premenopausal node-positive breast cancer: long-term results of an experience at the Milan Cancer Institute Tumori 86(3): 258-259
Gockerman, J.P.; Spremulli, E.N.; Raney, M.; Logan, T. 1986: Randomized comparison of tamoxifen versus diethylstilbestrol in estrogen receptor-positive or -unknown metastatic breast cancer: a Southeastern Cancer Study Group trial Cancer Treatment Reports 70(10): 1199-1203
Murphy, C.G.; Fornier, M. 2010: HER2-positive breast cancer: beyond trastuzumab Oncology 24(5): 410-415
Belohorska, B.; Svec, J.; Vertakova-Krakovska, B.; Tkacova, M. 2009: Treatment strategy of the HER 2 positive breast cancer with CNS metastases Bratislavske Lekarske Listy 110(5): 324
Santa-Maria, C.Augusto.; Nye, L.; Mutonga, M.B.; Jain, S.; Gradishar, W.J. 2016: Management of Metastatic HER2-Positive Breast Cancer: Where Are We and Where Do We Go From Here? Oncology 30(2): 148-155
Tahover, E.; Sonnenblick, A.; Peretz, T.; Katz, D. 2012: Update: adjuvant trastuzumab in HER2 positive breast cancer Harefuah 151(1): 37-42 61
Krsička, P.; Coufal, O.; Zapletal, O. 2013: Positive sentinel node in breast cancer - when and why also opt for axillary dissection? Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 92(12): 684-689
Mehta, R. 2008: HER2 and response to paclitaxel in node-positive breast cancer New England Journal of Medicine 358(2): 197-198; Author Reply 198
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
Fox, R.M.; Adiseshan, N. 1977: Adjuvant chemotherapy, early breast cancer and positive bone scan Medical Journal of Australia 1(10): 347-348
Lehrer, S.; Brown, R.R.; Lee, C.; Kalnicki, S.; Lipsztein, R.; Bloomer, W.D. 1988: Neuroendocrine abnormalities and the pathogenesis of estrogen-receptor-positive breast cancer Mount Sinai Journal of Medicine new York 55(4): 272-275
Wang, N.; Wang, Y.-j. 2010: How to optimize the clinical therapeutic protocol for triple-positive breast cancer Zhonghua Zhong Liu Za Zhi 32(4): 241-243
Wang, Y.; Li, J-jie.; Di, G-hong.; Lu, J-song.; Wu, J.; Liu, G-yu.; Hu, X-chun.; Wang, Z-hua.; Yang, W-tao.; Shao, Z-min. 2010: Retrospective analysis of trastuzumab treatment in 141 patients with Her-2 positive breast cancer Zhonghua Zhong Liu Za Zhi 32(11): 864-867
Yamamura, J.; Kamigaki, S.; Hamakawa, T.; Hoshino, H.; Nakata, K.; Yamamoto, T.; Ikeda, N.; Kawase, T.; Tsujie, M.; Kimura, Y.; Ozato, H. 2015: Efficacy and Safety of Pertuzumab for HER2-Positive Metastatic Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(6): 713-717